These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2824900)

  • 21. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
    Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K
    Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer].
    Yonei T; Ohnoshi T; Hiraki S; Yamashita H; Ishii J; Egawa T; Kozuka A; Moritaka T; Uji H; Yoshida M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Feb; 26(2):139-44. PubMed ID: 2841525
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble interleukin-2 receptors (sIL-2R) and neuron specific enolase (NSE) in small cell lung carcinoma.
    Sarandakou A; Poulakis N; Rizos D; Trakakis E; Phocas I
    Anticancer Res; 1993; 13(1):173-5. PubMed ID: 8386493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
    Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The "neuron-specific enolase" tumor marker as a prognostic indicator in small cell bronchial carcinoma].
    Hoster M; Kirchheiner T; Rühle KH
    Pneumologie; 1995 Aug; 49(8):470-4. PubMed ID: 7479642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer].
    Yumoto Y; Shiota T; Tamai M; Okabe K; Kiura K; Shimoe T; Fujii M
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2089-93. PubMed ID: 3013098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic usefulness of the determination of serum neuron-specific enolase in small cell bronchial carcinoma].
    Romero S; Padilla I; Mauri M; García-Sevila R; Martín C; Pérez-Carbonell A
    Med Clin (Barc); 1990 Jun; 95(1):10-4. PubMed ID: 2172670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report.
    Pettersson T; Klockars M; Fröseth B
    Eur Respir J; 1988 Aug; 1(8):698-700. PubMed ID: 2853080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum neuron-specific enolase as a marker of lung cancers].
    Fujisawa T; Yamaguchi Y; Sasaki K; Fukazawa T; Hongo H; Ogawa T; Kimura H
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):139-43. PubMed ID: 2981514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
    Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
    Popper H; Wirnsberger G; Hoefler H; Denk H
    Cancer Detect Prev; 1987; 10(3-4):167-74. PubMed ID: 2436780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of serum tumor marker in the diagnosis of lung cancer].
    Shi GL; Hu XL; Yue SD; Song CX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):299-301. PubMed ID: 15996327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuron-specific enolase in bronchial anaplastic small-cell cancer: a clinical case and review of the literature].
    Alamé T; Themelin D; Vincke G; Longeval E; Delmez JP
    Rev Med Brux; 1988 Apr; 9(3):155-7. PubMed ID: 2840726
    [No Abstract]   [Full Text] [Related]  

  • 38. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
    Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
    Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
    Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.